FDA rules not to ban textured implants
There has been a growing discussion in recent months around the safety of certain breast implants, with regulatory agencies around the world weighing the risk of breast implant associated anaplastic large cell lymphoma (BIA-ALCL). Following numerous evaluations by the Food and Drug Administration (FDA) in the United States, the decision has been made not to ban textured implants.
The full statement can be viewed here
Back to list page